Authors
ADEKUNLE SANYAOLU, PHD
FEDERAL MINISTRY OF HEALTH
Abuja, Nigeria
STEPHANIE PRAKASH, MD
ALEKSANDRA MARINKOVIC, MD, MS
SAINT JAMES SCHOOL OF MEDICINE
Anguilla
ZAHEEDA HOSEIN, MD
CARIBBEAN MEDICAL UNIVERSITY CURACAO CAMPUS
Willemstad, Curaçao
NAFEES HAIDER, MD
ALL SAINTS UNIVERSITY SCHOOL OF MEDICINE
Roseau, Saint George, Dominica
CHUKU OKORIE, MBBS, MPH
UNION COUNTY COLLEGE
Plainfield, New Jersey
Primary Audience: Pathologists and Clinical Scientists
Secondary Audience: Residents, Laboratory Technologist/Scientist (Includes all sub-specialty areas), Students, Pathologist Assistants, Laboratory Directors and Educators
Upon completion of this activity, you will be able to:
? describe the causative agent, risk factor, and transmission of COVID-19;
? discuss the clinical presentation of patients with SARS-CoV-2 infection;
? discuss the global epidemiology of the COVID-19 variant Omicron;
? discuss the pathogenesis of SARS-CoV-2 in relation to the viral mutation seen in Omicron and its sublineages and subvariants; and
? describe the implication of the Omicron mutation of the virus on transmission, diagnosis, prevention, control, treatment/management, and vaccination.